Anondita Medicare Limited has secured in-principle approval from the National Stock Exchange of India Limited to issue 2,85,000 convertible equity share warrants on a preferential basis to the Promoter Category. The warrants, priced at ₹1,038 each with a face value of ₹10, will convert into fully paid-up equity shares, providing capital infusion for the company. This approval, granted via letter No. NSE/LIST/55045 dated June 25, 2026, is subject to the company fulfilling specific conditions set by the exchange.

The issuance is governed by Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Upon conversion, each warrant will entitle the holder to one equity share. The approval enables the company to proceed with the allotment after securing necessary statutory clearances from authorities including SEBI, RBI, and MCA.

The National Stock Exchange has outlined several conditions for the final allotment. The company must file the listing application promptly after allotment and ensure compliance with all applicable guidelines, regulations, and directions of the exchange and statutory authorities. Additionally, Anondita Medicare is required to pay applicable fees and submit any documents requested by the exchange.

Compliance and Monitoring Requirements

The exchange has emphasized the need for strengthened internal controls to monitor trades executed by the proposed allottees. Anondita Medicare must obtain an undertaking from allottees confirming they will not engage in intra-day trading or sell the company's scrip until the allotment date. The responsibility for verifying this compliance and ensuring adherence to Regulation 167(6) of SEBI ICDR Regulations, 2018, rests solely with the issuer company.

Failure to comply with these conditions could result in the withdrawal of the in-principle approval or impact the listing of the resultant shares. The exchange reserves the right to revoke the approval if any information provided is found to be incomplete, incorrect, misleading, or in contravention of regulations.

Key Details of the Warrant Issue

Anondita Medicare Limited will participate in an investor conference titled 'India Inc. Unplugged' organized by PhillipCapital – Private Client Group on June 23, 2026. The management will engage with analysts and institutional investors during the in-person meeting scheduled at Grand Hyatt, Mumbai. The discussions will focus on generally available information and will not involve any unpublished price sensitive information in accordance with the company's code of practices for fair disclosure.

The participation is pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has stated that the schedule of the meeting is subject to change due to exigencies on the part of the fund, broking house, or the company.

Event Details

The following table outlines the specifics of the scheduled meeting:

The information regarding this meeting will be uploaded on the official website of anondita medicare . Bhawna Bisht, Company Secretary and Compliance Officer, signed the intimation submitted to the National Stock Exchange of India Limited on June 17, 2026.